Abstract
Objective: Supratentorial cortical ependymomas (CEs) are rare. These lesions, selectively occurring in the superficial cortex, have not been fully characterized. We analyzed the clinicopathological and genetic features of CEs. Methods: Eight patients with CEs from our institution and 84 other reported CE cases were included in the present study. We retrospectively reviewed their clinical characteristics, imaging findings, treatment methods, pathological features, molecular status, and clinical outcomes. Results: The median age at diagnosis of our 8 patients was 7.5 years. The mean tumor diameter was 70 mm. All the tumors had a cystic appearance, and calcification was observed in 6. Gross total resection was achieved in 6 patients and subtotal resection in 2 patients. Of the 8 tumors, 7 were World Health Organization grade III and 1 was World Health Organization grade II. Six tumors were immunopositive for L1 cell adhesion molecule (L1CAM). We investigated the presence of C11orf95–RELA fusion in 5 patients, all of whom exhibited it. Postoperative radiotherapy was performed for all patients with grade III tumors, except for children aged <3 years. Although 4 patients developed recurrence, all were alive throughout the follow-up period. Compared with previously reported CEs, our patients were younger and had larger tumors; however, the clinical outcomes did not differ significantly. Conclusions: Although most CEs in our group were immunopositive for L1CAM and showed C11orf95–RELA fusion, which have been associated with a poor prognosis in supratentorial ependymomas, all our patients had good outcomes. Gross total resection and adjuvant radiotherapy contributed to the relatively favorable prognosis of CEs compared with other supratentorial ependymomas.
| Original language | English |
|---|---|
| Journal | World Neurosurgery |
| DOIs | |
| Publication status | Published - Jan 1 2019 |
Fingerprint
Keywords
- C11orf95-RELA fusion
- Cortical
- Ependymoma
- L1CAM
ASJC Scopus subject areas
- Surgery
- Clinical Neurology
Cite this
Clinicopathological and Genetic Features of Supratentorial Cortical Ependymomas. / Matsumoto, Yuji; Ichikawa, Tomotsugu; Kurozumi, Kazuhiko; Otani, Yoshihiro; Date, Isao.
In: World Neurosurgery, 01.01.2019.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Clinicopathological and Genetic Features of Supratentorial Cortical Ependymomas
AU - Matsumoto, Yuji
AU - Ichikawa, Tomotsugu
AU - Kurozumi, Kazuhiko
AU - Otani, Yoshihiro
AU - Date, Isao
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Objective: Supratentorial cortical ependymomas (CEs) are rare. These lesions, selectively occurring in the superficial cortex, have not been fully characterized. We analyzed the clinicopathological and genetic features of CEs. Methods: Eight patients with CEs from our institution and 84 other reported CE cases were included in the present study. We retrospectively reviewed their clinical characteristics, imaging findings, treatment methods, pathological features, molecular status, and clinical outcomes. Results: The median age at diagnosis of our 8 patients was 7.5 years. The mean tumor diameter was 70 mm. All the tumors had a cystic appearance, and calcification was observed in 6. Gross total resection was achieved in 6 patients and subtotal resection in 2 patients. Of the 8 tumors, 7 were World Health Organization grade III and 1 was World Health Organization grade II. Six tumors were immunopositive for L1 cell adhesion molecule (L1CAM). We investigated the presence of C11orf95–RELA fusion in 5 patients, all of whom exhibited it. Postoperative radiotherapy was performed for all patients with grade III tumors, except for children aged <3 years. Although 4 patients developed recurrence, all were alive throughout the follow-up period. Compared with previously reported CEs, our patients were younger and had larger tumors; however, the clinical outcomes did not differ significantly. Conclusions: Although most CEs in our group were immunopositive for L1CAM and showed C11orf95–RELA fusion, which have been associated with a poor prognosis in supratentorial ependymomas, all our patients had good outcomes. Gross total resection and adjuvant radiotherapy contributed to the relatively favorable prognosis of CEs compared with other supratentorial ependymomas.
AB - Objective: Supratentorial cortical ependymomas (CEs) are rare. These lesions, selectively occurring in the superficial cortex, have not been fully characterized. We analyzed the clinicopathological and genetic features of CEs. Methods: Eight patients with CEs from our institution and 84 other reported CE cases were included in the present study. We retrospectively reviewed their clinical characteristics, imaging findings, treatment methods, pathological features, molecular status, and clinical outcomes. Results: The median age at diagnosis of our 8 patients was 7.5 years. The mean tumor diameter was 70 mm. All the tumors had a cystic appearance, and calcification was observed in 6. Gross total resection was achieved in 6 patients and subtotal resection in 2 patients. Of the 8 tumors, 7 were World Health Organization grade III and 1 was World Health Organization grade II. Six tumors were immunopositive for L1 cell adhesion molecule (L1CAM). We investigated the presence of C11orf95–RELA fusion in 5 patients, all of whom exhibited it. Postoperative radiotherapy was performed for all patients with grade III tumors, except for children aged <3 years. Although 4 patients developed recurrence, all were alive throughout the follow-up period. Compared with previously reported CEs, our patients were younger and had larger tumors; however, the clinical outcomes did not differ significantly. Conclusions: Although most CEs in our group were immunopositive for L1CAM and showed C11orf95–RELA fusion, which have been associated with a poor prognosis in supratentorial ependymomas, all our patients had good outcomes. Gross total resection and adjuvant radiotherapy contributed to the relatively favorable prognosis of CEs compared with other supratentorial ependymomas.
KW - C11orf95-RELA fusion
KW - Cortical
KW - Ependymoma
KW - L1CAM
UR - http://www.scopus.com/inward/record.url?scp=85068027136&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068027136&partnerID=8YFLogxK
U2 - 10.1016/j.wneu.2019.05.166
DO - 10.1016/j.wneu.2019.05.166
M3 - Article
C2 - 31150846
AN - SCOPUS:85068027136
JO - World Neurosurgery
JF - World Neurosurgery
SN - 1878-8750
ER -